hotspot -WSS

hotspot

author：explore 2025-10-02 13:01:42 - browse：4222

Kevin Sayer, CEO of Dexcom Dexcom

For years, diabetes tech company Dexcom has been striving to get its continuous glucose monitors into the hands of type 2 diabetes patients. Last week at the American Diabetes Association’s conference, the company unveiled plans for software built entirely for these patients, including ones who don’t take insulin.

“We’ve been so focused on things that match the needs of somebody who manages diabetes every minute of every day, and insulin delivery,” Kevin Sayer, CEO of Dexcom, told STAT. “This new product is going to be designed to address the needs of somebody with diabetes who’s not doing that, who has type 2 diabetes and is on other drugs.”

Continuous glucose monitoring is already well-established among people with type 1 diabetes, who rely on constant insulin therapy. The technology, which helps patients noninvasively monitor their blood sugar levels and control their insulin pump in real time, has grown rapidly in use over the years, culminating in a $5 billion market.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： There’s a way to spot data fakery. All journals should be using it

WSS

Stanford president’s abrupt resignation sparks debate

How to fix the rural physician shortage in the U.S.

Altering the blood type of lungs raises potential for universal organs for transplants

Inside the rise of 'mukbang' eating videos

Bispecific antibodies are next new thing in cancer immunotherapy

FDA approves first new drug developed for postpartum depression

hotspot

hotspot

entertainment

The high cost of giving birth even with insurance

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

Walensky prepares to leave CDC — and Congress — behind

'CMA Fest' 2023: How to watch, who is performing and more

Drug repurposing or repositioning? The language matters

Hormonal contraceptives don’t actually treat endometriosis

Wildfire smoke exposes gaps in outdoor worker protections

'CMA Fest' 2023: How to watch, who is performing and more

ChatGPT in medicine: STAT answers readers' burning questions

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

entertainment

Mom launches Girl Scout troop for LGBTQ youth in Texas

Biogen nominates mother of director’s child to replace him on board

After a decade, new Gardasil ad campaign gets it (mostly) right

5 dead in mass shooting on Caribbean island of St. Vincent: Police

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

Patients, doctors are clashing about side effects of hormonal birth control

hotspot

entertainment

focus

focus